Rankings
▼
Calendar
SMMT Q2 2021 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$57,000
-66.5% YoY
Gross Profit
$57,000
100.0% margin
Operating Income
-$24M
-41631.6% margin
Net Income
-$24M
-42835.1% margin
EPS (Diluted)
$-0.27
QoQ Revenue Growth
-70.3%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$146M
Total Liabilities
$26M
Stockholders' Equity
$119M
Cash & Equivalents
$103M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$57,000
$170,000
-66.5%
Gross Profit
$57,000
$170,000
-66.5%
Operating Income
-$24M
-$12M
-91.5%
Net Income
-$24M
-$15M
-60.3%
Revenue Segments
License and Service
$57,000
100%
Geographic Segments
Latin America
$57,000
100%
← FY 2021
All Quarters
Q3 2021 →